BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28388347)

  • 1. Endoscopic dacryocystorhinostomy following radioactive iodine thyroid ablation.
    Van Tassel SH; Segal KL; Hsu NM; Kacker A; Lelli GJ
    Orbit; 2017 Apr; 36(2):59-63. PubMed ID: 28388347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic dacryocystorhinostomy following head and neck radiation therapy.
    Sweeney AR; Davis GE; Chang SH; Jian-Amadi A
    Orbit; 2017 Feb; 36(1):30-34. PubMed ID: 28165837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lacrimal drainage system obstruction associated to radioactive iodine therapy for thyroid carcinoma].
    Fonseca FL; Lunardelli P; Matayoshi S
    Arq Bras Oftalmol; 2012; 75(2):97-100. PubMed ID: 22760799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Endoscopic Dacryocystorhinostomy in Secondary Acquired Nasolacrimal Duct Obstruction: A Case-Control Study.
    Sweeney AR; Davis GE; Chang SH; Amadi AJ
    Ophthalmic Plast Reconstr Surg; 2018; 34(1):20-25. PubMed ID: 27997463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasolacrimal obstruction secondary to I(131) therapy.
    Burns JA; Morgenstern KE; Cahill KV; Foster JA; Jhiang SM; Kloos RT
    Ophthalmic Plast Reconstr Surg; 2004 Mar; 20(2):126-9. PubMed ID: 15083081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma.
    Kloos RT; Duvuuri V; Jhiang SM; Cahill KV; Foster JA; Burns JA
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5817-20. PubMed ID: 12466391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated With Radioactive Iodine Therapy-Acquired Nasolacrimal Duct Obstruction.
    Lee IT; Chen W; Chen Q; Cole HA; Bischoff LA; Jessop AC; Sobel RK
    Endocr Pract; 2022 Dec; 28(12):1210-1215. PubMed ID: 35970353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary gland dysfunction and nasolacrimal duct obstruction: stenotic changes following I-131 therapy.
    Savage MW; Sobel RK; Hoffman HT; Carter KD; Finkelstein MW; Shriver EM
    Ophthalmic Plast Reconstr Surg; 2015; 31(3):e50-2. PubMed ID: 24836449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between radioactive iodine therapy for thyroid carcinoma and nasolacrimal drainage system obstruction.
    Cetinkaya A; Kersten RC
    Ophthalmic Plast Reconstr Surg; 2007; 23(6):496. PubMed ID: 18030131
    [No Abstract]   [Full Text] [Related]  

  • 10. Endonasal dacryocystorhinostomy for nasolacrimal duct obstruction in patients with sarcoidosis.
    Avisar I; McNab AA; Dolman PJ; Patel B; Desousa JL; Selva D; Malhotra R
    Orbit; 2013 Aug; 32(4):225-30. PubMed ID: 23662621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasolacrimal duct orifice cysts in adults: a previously unrecognized, easily treatable cause of epiphora.
    DelGaudio JM; Wojno T
    Laryngoscope; 2007 Oct; 117(10):1830-3. PubMed ID: 17690605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopically assisted balloon dacryoplasty treatment of incomplete nasolacrimal duct obstruction.
    Couch SM; White WL
    Ophthalmology; 2004 Mar; 111(3):585-9. PubMed ID: 15019340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma.
    Shepler TR; Sherman SI; Faustina MM; Busaidy NL; Ahmadi MA; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2003 Nov; 19(6):479-81. PubMed ID: 14625496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric endoscopic endonasal dacryocystorhinostomy in congenital nasolacrimal duct obstruction.
    Leibovitch I; Selva D; Tsirbas A; Greenrod E; Pater J; Wormald PJ
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1250-4. PubMed ID: 16538447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of rhinostomy shape and surgical outcome after endoscopic endonasal dacryocystorhinostomy.
    Lee J; Yang SW; Lee H; Chang M; Park M; Baek S
    Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1601-7. PubMed ID: 25712630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary endoscopic endonasal dacryocystorhinostomy for pediatric nasolacrimal duct obstruction: A systematic review.
    Saniasiaya J; Abdullah B; Husain S; Wang Y; Wan Mohammad Z
    Am J Rhinol Allergy; 2017 Sep; 31(5):328-333. PubMed ID: 28859711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacrimal intubation during dacryocystorhinostomy utilizing the STENTube.
    Shinder R; Wu A; Mehendale RA; Tang SX; Nasser QJ; Chou E; Sniegowski MC; Janda A; Shepler TR; Blaydon SM; Nakra T
    Orbit; 2017 Feb; 36(1):6-12. PubMed ID: 28145798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic dacryocystorhinostomy: long-term experience and outcomes.
    Coumou AD; Genders SW; Smid TM; Saeed P
    Acta Ophthalmol; 2017 Feb; 95(1):74-78. PubMed ID: 27573690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical Risk Prediction for Nasolacrimal Duct Obstruction in Radioactive Iodine-Treated Thyroid Cancer: A Nationwide Cohort Study.
    Lee JY; Woo KI
    Thyroid; 2022 May; 32(5):544-551. PubMed ID: 34894720
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of combined multispecialty endoscopic dacryocystorhinostomy.
    Kim C; Kacker A; Pearlman AN; Lelli GJ
    Orbit; 2013 Aug; 32(4):235-8. PubMed ID: 23662729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.